Devon Labs
Devon Labs is a Madrid-based pharmaceutical company that sells its own range of medicines and medical devices in three therapeutic areas: oncology, pain, and disorders of the central nervous system (CNS), including neurodegenerative diseases. It serves physicians, patients and caregivers, and pairs its products with digital telemedicine and patient- and caregiver-support tools. The company was founded in Madrid in 2019 by Gabriel Pérez Cuevas, a pharmaceutical executive who previously served as Senior Vice President for Southern Europe at Kyowa Kirin. In July 2022 it raised €4.5 million from Inveready through a mix of venture capital and venture debt from the Inveready Biotech III and Inveready Venture Finance III funds, to expand its commercial team across Spain and acquire exclusive rights to new products.
Founders
Global models 4
H
A
EIn the same niche 67 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 1
Open as list →
Funding rounds 1
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2022-07-07 | Series A (estimated) | €4.5M incl. debt: equity and debt, the split was not disclosed | Inveready |